Godoy, Mario Oliver
Godoy, Mario Oliver was paid $192K by Medicaid between Jan 2018 and Dec 2018, across 27 billing codes. Its largest line is 95004, Percutaneous tests with allergenic extracts, immediate type reaction — 38% of everything it billed.
33Billing provider infoGODOY, MARIO OLIVER
LAS VEGAS, NV 89106
LAS VEGAS, NV 89106
33aNPI1275822611assigned 04/06/2011
33bProvider typeRegistered Nurse
28Total paid$192K
24GClaims4,397
24DCodes billed27
24AFirst – last monthJan 2018 – Dec 2018
Compared with peers
Next to other Registered Nurse providers in Nevada
Rank by total paid#3 of 37
Median peer was paid$13K
This provider vs. median14×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,397 | $192K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 38% | 326 | 319 | $73K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 28% | 924 | 858 | $53K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 12% | 549 | 530 | $22K |
| 94060 | 3.2% | 133 | 131 | $6K | |
| 94729 | 2.9% | 132 | 130 | $6K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.7% | 88 | 82 | $5K |
| 94727 | 2.2% | 132 | 130 | $4K | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 2.1% | 296 | 286 | $4K |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 1.8% | 66 | 62 | $3K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 1.5% | 85 | 85 | $3K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.1% | 182 | 181 | $2K |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | <1% | 18 | 18 | $2K |
15 more codes
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 303 | $2K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 13 | $1K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 12 | $944.55 |
| 94200 | <1% | 131 | $782.88 | |
| 92561 | <1% | 23 | $671.26 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 47 | $551.88 |
| 99188 | <1% | 37 | $455.10 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 459 | $299.95 |
| 85018 | <1% | 50 | $121.32 | |
| 81000 | <1% | 42 | $93.01 | |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 46 | $81.22 |
| 94760 | <1% | 42 | $76.80 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 48 | $16.70 |
| 99000 | 0% | 176 | $0.00 | |
| 99173 | 0% | 37 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.